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Available online 16 July 2015AbstractPurpose: To describe the imaging characteristics of the upper urinary tract (UUT) in addition to the bladder on computed tomography (CT) in
adult patients with late-onset hemorrhagic cystitis (LOHC) after allogeneic hematopoietic stem cell transplantation (HSCT).
Subjects and methods: This retrospective study included 24 patients with LOHC who underwent urinary system CT between April 2006 and
August 2013. UUT and bladder wall thickness and attenuation were measured before and after contrast material administration. Kidney density,
collecting system dilatation, mucosal enhancement, submucosal edema, perivesical stranding around the UUT and bladder, and intravesical clots
were evaluated. Diffuse and/or focal renal pelvis and ureter and bladder wall thickening were identified. Correlations between LOHC degree and
UUT thickness, UUT attenuation, and uronephrosis were analyzed using Spearman's rank correlation coefficient.
Results: Diffuse and/or focal severe UUT and bladder wall thickening was observed in 22 patients (91.7%) with LOHC after HSCT. The median
UUT and bladder wall thicknesses (interquartile range) were 2.5 mm (1.0e4.6 mm) and 4.8 mm (3.1e7.3 mm), respectively. Collecting system
dilation (17; 70.8%), stranding surrounding the UUT and bladder (19; 79.2%), and intraluminal clots (two; 8.3%) were noted. Three patients
underwent ureteral balloon dilation and D-J catheter implantation to resolve irreversible ureteral stenosis and uronephrosis. No significant
positive correlation was seen between LOHC classification, UUT wall thickness or attenuation, or uronephrosis (P > 0.05).
Conclusion: UUT and bladder wall thickening and uronephrosis were observed on CT in patients with LOHC after allogeneic HSCT. Surgical
treatment may be needed for irreversible ureteral stenosis.
© 2015 The Authors. Production and hosting by Elsevier B.V. On behalf of Beijing You’an Hospital affiliated to Capital Medical University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Allogeneic hematopoietic stem cell transplantation; Late-onset hemorrhagic cystitis; Upper urinary tract; Computed tomography imaging1. Introduction
Hemorrhagic cystitis (HC) is a common complication after
allogeneic hematopoietic stem cell transplantation (HSCT)
that results in prolonged hospitalization and occasionally
death [1,2]. The reported incidence of HC varies widely
(5e70%) because of discrepancies in definition criteria [3e5].
Early-onset HC occurs within 48e72 h of a conditioning* Corresponding author.
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In comparison, late-onset HC (LOHC) occurs beyond
72 h after the preparative regimen and its pathogenesis has not
been well elucidated [7]. As shown in prior studies, multiple
potential etiologies including immunological mechanisms,
graft-versus-host disease (GVHD), and viral infection may be
associated with LOHC [4,8e10].
Because of patients' immunocompromised conditions,
early imaging may be helpful after HSCT to define the extent
of urinary tract disease and demonstrate complications. Pa-
tients with a diagnosis of LOHC would be referred for im-
aging if they did not respond to treatment and had atypical or
severe symptoms [11,12]. In previous studies, bladder wallf of Beijing You’an Hospital affiliated to Capital Medical University. This is an
licenses/by-nc-nd/4.0/).
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CT images in patients who had LOHC. In addition, intra-
vesical clots and a sloughed uroepithelial lining was seen on
CT imaging in some severe cases [13]. To our knowledge,
however, no study has attempted to elucidate upper urinary
tract (UUT) abnormalities (including those in the renal pelvis
and ureter) using CT examinations in patients with LOHC
after HSCT.
The aim of this study was proposed to identify the imaging
characteristics on CT of the upper urinary tract in patients who
were diagnosed with LOHC after allogeneic HSCT.
2. Materials and methods2.1. PatientsOur institutional review board approved this retrospective
study but waived the need for informed consent. Using a
proprietary search engine developed by our imaging infor-
matics department, an electronic search of medical record
system database between April 2006 and August 2013 was
performed to identify patients with a diagnosis of LOHC post-
allogeneic hematopoietic stem cell transplantation (HSCT).
Patients who underwent urinary system examination with or
without a contrast CT examination were included in this study.
Patients with bacterial, fungal, and tubercular urinary tract
infections were excluded from this study based on history as
well as physical examination and laboratory test results. The
final cohort in this study consisted of 24 patients (13 women,
11 men; mean age, 26 years; range, 18e44 years). The median
interval between LOHC onset and CT examination was 2.9
months (range, 1.5e9 months).2.2. Clinical recordThe clinical symptoms of patients with LOHC including
hematuria, dysuria, abdominal pain, and uronephrosis were
assessed and recorded. LOHC severity was graded and defined
according to hemorrhage degree as follows: grade I, micro-
scopic hematuria; grade II, macroscopic hematuria; grade III,
macroscopic hematuria with clots; and grade IV, macroscopic
hematuria that requires instrumentation for clot evacuation
[14]. The diagnosis of acute GVHD was also recorded. The
plasma polymerase chain reaction assay (Amplicor; Roche,
Inc., Branchburg, N.J.) for cytomegalovirus (CMV) was
analyzed weekly after transplantation until day 10 [4].2.3. CT techniqueUrinary system CT examinations were performed using a
multi-detector row CT scanner (Light Speed Volume CT; GE
Healthcare, Milwaukee, WI, USA). CT images were obtained
using the following parameters: 120 kV, 240e260 mAs, col-
limations of 64e0.6, slice thicknesses and increments of
5 mm, and sagittal and coronal reconstructions of 3 mm.
Dynamic contrast-enhanced CT examinations were performed
60 s and 2e5 min after the intravenous administration of80 mL of contrast material at a flow rate of 3 mL/s (iopromide
370 mg J/mL; Bayer Schering Pharma, Berlin, Germany).
According to our routine urinary system CT imaging pro-
tocol, all patients were asked to ingest 500e600 mL of water.
A Foley catheter was clamped prior to the CT imaging
acquisition to adequately distend the bladder. If the patient felt
uncomfortable, the procedure was stopped.2.4. Image analysisTwo radiologists (J.C. and Y.W.) with 10 and 17 years'
experience in body imaging who were blinded to the medical
records and other imaging studies reviewed the CT images to
consensus.
The entire wall layers of the UUT and bladder were
measured. Based on the modified Nicolet system, the UUT and
bladder wall were classified as follows: none, imperceptible;
grade 1, 2 mm; grade 2, 3e5 mm; and grade 3, >5 mm [15].
Abnormalities of the UUTand bladder wall distributed from the
renal pelvis to the bladder were identified as diffuse thickening,
while those of the UUT and bladder wall separated by normal-
appearing sections were identified as focal thickening.
Mucosal stratification was distinguished by different CT
attenuation values of the UUT and bladder wall layer resulting
from infection-related pathophysiological changes. Attenua-
tion of the UUT and bladder mucosa (uroepithelium) was
measured and recorded before and after administration of
contrast material using crosshair tools (pixel attenuation). Due
to infection-related edema, muscularis propria can be distinct
from mucosa, so this was evaluated and recorded.
Kidney parenchyma density was evaluated before and after
contrast material administration. Collecting system dilation
from the renal pelvis to the distal urinary tract was recorded.
Intravesical clots were identified and recorded by higher
attenuation values and good delineation from urine.2.5. Statistical analysisUrinary tract wall thickness and attenuation are reported as
median values with interquartile ranges (IQR). The correlation
between LOHC degree and UUT thickness and attenuation
was analyzed by the nonparametric method of Spearman's
rank correlation coefficient. The same statistical method was
used to assess the relationship between LOHC degree and
collecting system dilation. P values  0.05 were required in all
tests to reject the null hypothesis. Statistical analyses were
performed using MedCalc software (MedCalc Software,
Mariakerke, Belgium).
3. Results3.1. Patient demographicsPatients' clinical data are shown in Table 1. All patients in
this cohort had LOHC with urinary tract irritation after hap-
loidentical HSCT (23/24; 95.8%) or identical allogeneic
HSCT (1/24; 4.2%). The median interval between the
Table 1
Patients' demorgraphic data.
No. Age(years) Gender Disease CMV uraemia GVHD HC grade
1 36 M ALL e þ 2
2 23 M ALL þ þ 1
3 13 F ALL þ þ 3
4 31 F AML þ e 4
5 35 F AML þ þ 3
6 19 F ALL þ þ 4
7 30 M CML þ þ 1
8 24 M AML e þ 2
9 18 F ALL þ e 1
10 23 F ALL þ þ 4
11 19 F ALL þ þ 2
12 22 M AML þ þ 3
13 22 M ALL þ þ 3
14 13 M ALL þ þ 2
15 26 F AML þ þ 2
16 27 M AML e þ 4
17 36 M AML þ þ 2
18 32 F AML þ þ 2
19 25 M AML þ þ 3
20 21 M ALL þ þ 2
21 37 F CML þ þ 2
22 44 F AML þ e 2
23 20 F ALL þ þ 3
24 29 F ALL þ þ 4
ALL ¼ acute lymphoid leukemia, AML ¼ acute myeloid leukemia,
CML ¼ chronic myeloid leukemia.
Fig. 1. A 23-year-old female patient who had acute lymphoblastic leukemia
presented HC 2 months after allogeneic HSCT. Diffuse thickening of the
bladder wall (white arrow) with delineation of the inner layers (curved arrow)
was shown on axial CECT. A large intravesical clot was detected on the CT
images (empty arrow).
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9e120 days). All patients in this study had different degrees of
hematuria as follows: four had grade I LOHC, 10 had grade II
LOHC, six had grade III LOHC, and four had grade IV
LOHC. CMV viremia was demonstrated in 21 patients (21/24;
87.5%). Acute GVHD was diagnosed in 21 patients (21/24;
87.5%) after allogeneic HSCT. Patients in this study presented
with abdominal pain (20/24) and uronephrosis observed using
ultrasonography (4/24) prior to the urinary system CT
examination.3.2. Imaging characteristicsPatients' imaging characteristics are shown in Table 2.
Diffuse thickening of the bladder wall was observed with a
median thickness of 4.8 mm (IQR, 3.1e7.3 mm). Intravesical
clots were observed in only 2 patients (2/24, 8.4%) with grade
IV LOHC on CT images. The mucosal layer of the bladder
wall clearly indicated with median attenuation of 52.5 (IQR,
40.0e60.0) and 100.0 HU (IQR, 90.8e140.0 HU) before andTable 2
Imaging characteristics.
Wall thickness (median, interquartile range)
Attenuation of urinary tract wall before contrast (median, interquartile range)
Attenuation of urinary tract wall after contrast (median, interquartile range)
Submucosal edema (n)
Dilation of collecting system (n)
Surrounded stranding (n)
Intravesical clots (n)after contrast material administration in nine patients (9/9;
100%). Submucosal edema of the bladder wall was also seen
in these nine patients (9/9; 100%) on CT images with contrast
(Fig. 1). Perivesical stranding was observed in 19 patients (19/
24; 79.2%).
Diffuse thickening of the UUT wall only was demonstrated
in 22 patients (22/24; 91.7%). The median pelvis and ureter
wall thickness was 2.5 mm (IQR, 1.0e4.6 mm; Figs. 2 and 3).
According to the modified Nicolet system, grade 1 and 2
thickening of the renal pelvis and ureter wall was obtained in
10 and 12 patients, respectively, while no thickening of the
renal pelvis and ureter wall was seen in two patients. Sixteen
patients (16/24; 66.7%) had bilateral renal pelvis and ureter
wall thickening, while six patients (6/24; 30.0%) had unilat-
eral renal pelvis and ureter wall thickening.
Increased attenuation of UUT mucosal and submucosal
edema was seen in five patients (5/9; 55.6%). Meanwhile,
homogeneous enhancement of all layers of the pelvis and
ureter walls was noted in four patients (4/9; 44.4%). The
median intensity of the UUT wall was 45.0 (IQR,
39.0e48.8 HU) and 100.0 HU (IQR, 90.8e111.3 HU) before
and after contrast material administration (Fig. 4), respec-
tively. Stranding surrounding the UUT was seen in 19 patients
(19/24; 79.2%), while a dilated collecting system was seen in
17 patients (17/24; 70.8%; Fig. 3).Bladder Renal pelvis and ureter
4.8 mm (3.1e7.3) 2.5 mm (1.0e4.6)
52.5 HU (40.0e60.0) 45.0 HU (39.0e48.8)





Fig. 2. A 37-year-old female patient who had chronic myeloid leukemia
presented HC 3 months after allogeneic HSCT. Diffuse thickening of renal
pelvis and ureter wall with homogeneous enhancement of all layers (black
arrows) was shown on the coronal reconstruction CECT image.
Fig. 3. A 20-year-old female patient who had acute lymphoblastic leukemia
presented HC 2 months after allogeneic HSC. Diffuse thickening with ho-
mogeneous enhancement of the ureter wall was shown on the oblique sagittal
reconstruction CECT image (white arrow), which suggests mild uronephrosis
(empty arrow).
Fig. 4. A 30-year-old male patient who had chronic myeloid leukemia pre-
sented HC 2 months after allogeneic HSCT. Thickening of the right ureter wall
with obvious enhancement of the inner layer (black arrow) was shown on axial
CECT. The slight enhancement of the outer layers detected was associated
with submucous edema (white arrow).
Fig. 5. An 18-year-old female patient who had acute lymphoblastic leukemia
presented HC 2 months after allogeneic HSCT. Heterogeneous enhancement
of kidney parenchyma was shown on axial CECT (black arrow).
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seen on CT images without contrast, whereas poor and het-
erogeneous enhancement was observed in three patients (3/9;
33.3%) on CT images after contrast material administration
(Fig. 5).
No significant positive correlation was seen between LOHC
degree and UUT wall thickening (P > 0.05) or UUT wall
attenuation (P > 0.05) or between LOHC degree and col-
lecting system dilation (P > 0.05).Median follow-up time was 14.5 months (IQR, 3e60
months). Three patients (3/24; 12.5%) underwent ureter
balloon dilation and D-J catheter implantation to resolve
irreversible ureter stenosis and uronephrosis. No correlation
was seen between urinary tract infection and overall survival
outcomes. Five patients died of pulmonary infection and one
patient died of cerebral infection.
4. Discussion
In this study, we demonstrated CT abnormalities of the
UUT in addition to the bladder in patients with LOHC after
HSCT. Diffuse thickening walls and dilation of the pelvis and
92 J. Cheng et al. / Radiology of Infectious Diseases 2 (2015) 88e93ureter were seen on the CT images. Mucosal hyperemia and
submucosal edema of the UUT and bladder were seen as
enhanced inner or all layers on CT images. Stranding sur-
rounding the UUT as well as striated nephrograms was also
seen.
In general, ultrasound has been used to assess clots,
thickening bladder wall, and urethral obstruction in patients
with LOHC. CT is not routine examination for assessment of
LOHC in clinical settings [13]. However, CT imaging
demonstrated diffuse thickening wall and enhanced inner or all
layer walls from bladder to renal pelvis in this study. In
addition, the enhancement of mucosa and submucosa edema
can be distinguished by using CT imaging after contrast.
Similar to our results, the bladder changes in patients with
LOHC were detected by using CT in prior publications as a
common complication in patients after HSCT [13,16].
Schulze et al. reported the continuous thickening bladder wall
in patients with polyomavirus hominis type 1 (BKV) LOHC
after allogeneic HSCTon CT imaging. The detailed changes in
wall of UUT and bladder could not be clearly detected only by
using ultrasonography, especially when obvious uronephrosis
did not present.
In addition, the mucosal enhancement related with hyper-
emia was also obtained after administration of contrast [13].
The LOHC was graded based on the severity of hematuria,
which may associate with the inflammation of mucosa. Ac-
cording to the prior study, inflammatory hyperemia may be
indicated by the enhancement of mucosa after administration
of contrast on CT imaging. We tried to measure the attenuation
of urinary mucosa on CT imaging; however, the positive
correlation with HC grade was not seen. It needed further
study with larger sample size to clarify the relationship be-
tween inflammation of mucosa and grade of LOHC.
Uronephrosis is reportedly a complication of LOHC in
severe cases of bladder clot obstruction [20,21]. In the study,
only two patients had the clots in bladder. The major imaging
abnormality of HC in this study was the wall thickening from
bladder to renal pelvis that reflected the submucosa edema. A
high proportion (17/24; 70.8%) of our patients presented with
collecting system dilation on CT imaging that may associated
with wall thickening of distal ureter and bladder. Moreover,
three patients (3/24; 12.5%) underwent D-J catheter implan-
tation to solve irreversible ureteral stenosis and uronephrosis
obtained on the follow-up examination. UUT and bladder
fibrosis and contracture in patients with LOHC may lead to
lifelong sequelae [21]. The closely relationship between the
thickening of UUT and irreversible ureter stenosis was not
demonstrated in this study involved such small sample size.
The further study with larger sample size is needed to
demonstrate the factor contributed to ureter stenosis.
Tonolini et al. reported on the imaging features of acute
pyeloureteritis caused by bacteria or fungus in HIV-positive pa-
tients. Subtly decreased parenchymal attenuation and mild-to-
moderate pelvicalyceal or ureteral thickening was commonly
observed in the nephrographic phase. In some cases, a thickening
urinary tract was seen as the only perceptible feature of acute
urinary tract infection [17]. Tuberculous infection with ureteralinvolvement also presented as ureteral wall thickening or distal
ureteral strictures [18].
These non-specific imaging characteristics, including
diffuse thickening of the UUT and bladder walls, mucosal
hyperemia, submucosal edema, and collecting system dilation,
might not be used as added clues for making a pathogenic
diagnosis. In a clinic workshop, history, physical examination,
and laboratory tests played major roles in the identification of
pathogens in patients with immunocompromised conditions,
especially after HSCT. BKV and CMV have been reported as
independent risk factors of LOHC in patients after HSCT
[1,4,15,19]. CMV seropositivity has been observed in up to
95% of adult donors and recipients because of the high
prevalence of CMV infection in China [4]. As Xu et al. re-
ported, CMV viremia was significantly associated with an
increased incidence of LOHC based on univariate analysis [4].
In accordance with the earlier study, CMV viremia was
confirmed in 21 patients (21/24; 87.5%) of this cohort. Acute
GVHD, chemical toxins, immunological mechanisms, and
radiation also contributed to LOHC development [19]. Even
though the UUT abnormalities in patients with LOHC have not
been reported, they might be induced by multiple potential
etiologies similar to LOHC.
This study has some potential limitations. First, patients
with symptoms such as abdominal pain and/or uronephrosis
would be referred for CT examination although LOHC was a
common complication in patients after HSCT. Accordingly,
we may have missed some asymptomatic cases in this retro-
spective study. The second potential limitation was the lack of
histopathological data from all patients with urinary tract
disorders, which could not be obtained for obvious ethical
reasons. As such, biopsy or surgical pathological validation is
still needed in a further study to analyze the corresponding
imaging characteristics.
In conclusion, wall thickening of the UUT in addition to the
bladder as well as uronephrosis in patients with LOHC after
allogeneic HSCT was observed on CT. These CT imaging
findings can increase our awareness of possible irreversible
ureteral stenosis and may help identify the need for further
surgical treatment.
References
[1] Seber A, Shu XO, Defor T, Sencer S, Ramsay N. Risk factors for severe
hemorrhagic cystitis following BMT. Bone Marrow Transpl
1999;23(1):35e40.
[2] El-Zimaity M, Saliba R, Chan K, Shahjahan M, Carrasco A, Khorshid O,
et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell
transplantation: donor type matters. Blood 2004;103(12):4674e80.
[3] Giraud G, Bogdanovic G, Priftakis P, Remberger M, Svahn BM,
Barkholt L, et al. The incidence of hemorrhagic cystitis and BK-viruria in
allogeneic hematopoietic stem cell recipients according to intensity of the
conditioning regimen. Haematologica 2006;91(3):401e4.
[4] Xu LP, Zhang HY, Huang XJ, Liu KY, Liu DH, Han W, et al. Hemorrhagic
cystitis following hematopoietic stem cell transplantation: incidence, risk
factors and association with CMV reactivation and graft-versus-host dis-
ease. Chin Med J Engl 2007;120(19):1666e71.
[5] Gorczynska E, Turkiewicz D, Rybka K, Toporski J, Kalwak K, Dyla A,
et al. Incidence, clinical outcome, and management of virus-induced
hemorrhagic cystitis in children and adolescents after allogeneic
93J. Cheng et al. / Radiology of Infectious Diseases 2 (2015) 88e93hematopoietic cell transplantation. Biol Blood Marrow Transpl
2005;11(10):797e804.
[6] Cox PJ. Cyclophosphamide cystitis e identification of acrolein as the
causative agent. Biochem Pharmacol 1979;28(13):2045e9.
[7] Russell SJ, Vowels MR, Vale T. Haemorrhagic cystitis in paediatric bone
marrow transplant patients: an association with infective agents, GVHD
and prior cyclophosphamide. Bone Marrow Transpl 1994;13(5):533e9.
[8] Akiyama H, Kurosu T, Sakashita C, Inoue T, Mori Si, Ohashi K, et al.
Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone
marrow transplantation. Clin Infect Dis 2001;32(9):1325e30.
[9] Erard V, Kim HW, Corey L, Limaye A, Huang ML, Myerson D, et al. BK
DNA viral load in plasma: evidence for an association with hemorrhagic
cystitis in allogeneic hematopoietic cell transplant recipients. Blood
2005;106(3):1130e2.
[10] Hale GA, Rochester RJ, Heslop HE, Krance RA, Gingrich JR, Benaim E,
et al. Hemorrhagic cystitis after allogeneic bone marrow transplantation
in children: clinical characteristics and outcome. Biol Blood Marrow
Transpl 2003;9(11):698e705.
[11] Browne RF, Zwirewich C, Torreggiani WC. Imaging of urinary tract
infection in the adult. Eur Radiol 2004;3(14 Suppl.):E168e83.
[12] Symeonidou C, Standish R, Sahdev A, Katz RD, Morlese J, Malhotra A.
Imaging and histopathologic features of HIV-related renal disease. Ra-
diographics 2008;28(5):1339e54.
[13] Schulze M, Beck R, Igney A, Vogel M, Maksimovic O, Claussen CD,
et al. Computed tomography findings of human polyomavirus BK
(BKV)-associated cystitis in allogeneic hematopoietic stem cell trans-
plant recipients. Acta Radiol 2008;49(10):1187e94.[14] Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P,
et al. Association of BK virus with failure of prophylaxis against hem-
orrhagic cystitis following bone marrow transplantation. J Clin Oncol
1995;13(5):1103e9.
[15] Bogdanovic G, Priftakis P, Taemmeraes B, Gustafsson A, Flaegstad T,
Winiarski J, et al. Primary BK virus (BKV) infection due to possible
BKV transmission during bone marrow transplantation is not the major
cause of hemorrhagic cystitis in transplanted children. Pediatr Transpl
1998;2(4):288e93.
[16] Cartoni C, Arcese W, Avvisati G, Corinto L, Capua A, Meloni G. Role of
ultrasonography in the diagnosis and follow-up of hemorrhagic cystitis
after bone marrow transplantation. Bone Marrow Transpl
1993;12(5):463e7.
[17] Tonolini M, Bianco R. Mesenterial, omental, and peritoneal disorders in
antiretroviral-treated HIV/AIDS patients: spectrum of cross-sectional
imaging findings. Clin Imaging 2013;37(3):427e39.
[18] Zissin R, Gayer G, Chowers M, Shapiro-Feinberg M, Kots E, Hertz M.
Computerized tomography findings of abdominal tuberculosis: report of
19 cases. Isr Med Assoc J 2001;3(6):414e8.
[19] Hassan Z, Remberger M, Svenberg P, Elbander M, Omazic B,
Mattsson J, et al. Hemorrhagic cystitis: a retrospective single-center
survey. Clin Transpl 2007;21(5):659e67.
[20] Riachy E, Krauel L, Rich BS, McEvoy MP, Honeyman JN, Boulad F,
et al. Risk factors and predictors of severity score and complications in
pediatric hemorrhagic cystitis. J Urol 2014;191(1):186e92.
[21] Decker DB, Karam JA, Wilcox DT. Pediatric hemorrhagic cystitis.
J Pediatr Urol 2009;5(4):254e64.
